Management of the Patient at High Risk Hemorrhagic in Cardiac Surgery by Monitoring Viscoelastic Hemostasis.
CompletedOBSERVATIONAL
Enrollment
30
Participants
Timeline
Start Date
March 20, 2020
Primary Completion Date
March 20, 2022
Study Completion Date
March 23, 2022
Conditions
Cardiac Surgery
Trial Locations (1)
29200
CHRU BREST, Hôpital de la Cavale Blanche, Brest
All Listed Sponsors
lead
University Hospital, Brest
OTHER
NCT06550505 - Management of the Patient at High Risk Hemorrhagic in Cardiac Surgery by Monitoring Viscoelastic Hemostasis. | Biotech Hunter | Biotech Hunter